Note: Revenues for privately held companies are statistical evaluations.
Rockland Immunochemicals's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Scientific Research & Development Services industry.
Note: Rockland Immunochemicals's revenues are gauged from an analysis of company filings.
Rockland Immunochemicals's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Rockland Immunochemicals Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Rockland Immunochemicals is developing and marketing.
Rockland Immunochemicals doesn't have any recent trademark applications, indicating Rockland Immunochemicals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
EPI-PLUS Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
Determine whether Rockland Immunochemicals grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Rockland Immunochemicals is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Rockland Immunochemicals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Rockland Immunochemicals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Rockland Immunochemicals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Rockland Immunochemicals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.